Results 241 to 250 of about 2,292,196 (319)
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Modulating Placebo Effects in Clinical Trials: Study Team Briefing to Optimize Drug-Placebo Differences. [PDF]
Coenen M +8 more
europepmc +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
Women's Satisfaction with Gynecological Healthcare Services in a Public Tertiary Facility: A Questionnaire Study. [PDF]
Gawron I +5 more
europepmc +1 more source
The Customer Expectation and Satisfaction on Online Food Order From Restaurant in Chennai
J Andrews +13 more
openalex +1 more source
Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley +1 more source
On a result of K. P. Hart about non-existence of measurable solutions to the discrete expectation maximization problem [PDF]
Vladimir Pestov
openalex +1 more source

